Diagnosis and treatment of epidemic myalgia: A review of the literature over the last 10 years
DOI:
https://doi.org/10.33448/rsd-v12i10.43307Keywords:
Epidemic myalgia; Epidemic pleurodynia; Bornholm disease.Abstract
Epidemic myalgia, also known as epidemic myositis, is a condition characterized by severe, widespread muscle pain. This condition may be associated with several viruses, such as influenza, Coxsackie, Epstein-Barr, herpes simplex, parainfluenza, adenovirus, among others. Myalgia may occur in cases of epidemic pleurodynia, known as Bornholm syndrome, caused mainly by enteroviruses. Bornholm syndrome affects the intercostal muscles, resulting in severe intermittent chest pain, fever, sore throat, headache, and myalgia. Furthermore, myalgia can occur in cases of infection with Parechovirus (HPeV), an RNA virus of the Picornaviridae family. HPeV3, in particular, has been linked to infections in children before the age of 5, causing symptoms of myalgia and muscle weakness, mainly affecting the proximal muscles of the legs and arms. This article aims to study the epidemiological and clinical aspects of epidemic myalgia in the last 10 years. Specific objectives include analyzing the epidemiology of the cases, identifying the related etiological agents, describing the clinical presentation and discussing diagnostic and therapeutic approaches. Thus, the method used was that of a systematic literature review, whose objective was to synthesize, in a methodical and impartial way, the available evidence about epidemic myalgia and its respective diagnosis and treatment. Based on results, it was possible to identify that the diagnosis is performed by laboratory tests, such as antibody detection and virus sequencing, which can affect both children and adults, with severe and persistent symptoms, thus, treatment involves the use of analgesics and anti-inflammatories, seeking only to minimize the symptoms.
References
Bernardo, W. M., Nobre, M. R., & Jatene, F. B. (2004). Evidence-based clinical practice. Part II—Searching evidence databases. Revista da Associação Médica Brasileira, 50(1), 104-108.
Guixeres Esteve, T., Moriano Gutiérrez, A., & Insa Albert, B. (2015). Guia de Algoritmos em Pediatria de Atenção Primária. Dolor torácico. AEPap
Kenzaka, T., Hida, Y., Matsumoto, M., & Akita, H. (2016). A case of epidemic myalgia with symptoms resembling acute purulent spondylitis and discitis. BMC Musculoskeletal Disorders, 17, 323. https://doi.org/10.1186/s12891-016-1181-x
Leendertse, M., van Vugt, M., Benschop, K. S., van Dijk, K., Minnaar, R. P., van Eijk, H. W., & Wolthers, K. C. (2013). Pleurodynia caused by an echovirus 1 brought back from the tropics. Journal of Clinical Virology, 58(2), 490-493. https://doi.org/10.1016/j.jcv.2013.06.039
Marques, B. A., Costa, G. A., & Bentes, A. A. (2017). Mialgia aguda epidêmica. Revista de Medicina de Minas Gerais, 27(Supl 3), S68-S72. https://doi.org/10.5935/2238-3182.20170033
Masuda, S., Koizumi, K., Sato, M., Uojima, H., Kimura, K., Nishino, T., & Kobayashi, M. (2022). Severe Generalized Epidemic Myalgia in an Adult due to Human Parechovirus Type 3: A Case Report. Cureus, 14(10), e30587. https://doi.org/10.7759/cureus.30587
Miyazaki, M., Hara, K., Takayoshi, T., Kawase, T., Nakagawa, Y., Arai, T., & Yokono, K. (2020). Epidemic Myalgia Associated with Human Parechovirus Type 3 Infection. Internal Medicine, 59(5), 739-744. https://doi.org/10.2169/internalmedicine.3326-19
Mizuta, K., Yamakawa, T., Kurokawa, K., Chikaoka, S., Shimizu, Y., Itagaki, T., & Yahagi, K. (2016). Epidemic myalgia and myositis associated with human parechovirus type 3 infections occur not only in adults but also in children: findings in Yamagata, Japan, 2014. Epidemiology and Infection, 144(6), 1286-1290. https://doi.org/10.1017/S0950268815002873
Mizuta, K., Yamakawa, T., Nagasawa, H., Itagaki, T., Katsushima, F., Katsushima, Y., & Kimura, H. (2013). Epidemic myalgia associated with human parechovirus type 3 infection among adults occurs during an outbreak among children: findings from Yamagata, Japan, in 2011. Journal of Clinical Virology, 58(1), 188-193. https://doi.org/10.1016/j.jcv.2013.05.019
Nakamura, K., Saito, K., Hara, Y., Aoyagi, T., Kitakawa, K., Abe, Y., & Kanemitsu, K. (2018). Severe epidemic myalgia with an elevated level of serum interleukin-6 caused by human parechovirus type 3: a case report and brief review of the literature. BMC Infectious Diseases, 18(1), 381. https://doi.org/10.1186/s12879-018-3284-5
NHS Choices. (2014, 10 de setembro). Bornholm disease. NHS Choices.
Orimo, K., Hatano, K., Sato, N., Okabe, S., Suzuki, A., Mori, K., & Hashida, H. (2020). Clinical Characteristics of Epidemic Myalgia Associated with Human Parechovirus Type 3 during the Summer of 2019. Internal Medicine, 59(14), 1721-1726. https://doi.org/10.2169/internalmedicine.4416-20
Secretaria da Saúde do Estado da Bahia. (2016). Diretoria de Vigilância Epidemiológica. Alerta Epidemiológico. Salvador–Bahia. http://valencaagora.com/wp-content/uploads/2016/12/Leia-o-ALERTA- -EPID
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Caroline Nascimento Menezes; Matheus Todt Aragão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
